Growth Metrics

SELLAS Life Sciences Group (SLS) Capital Expenditures: 2010-2016

Historic Capital Expenditures for SELLAS Life Sciences Group (SLS) over the last 6 years, with Dec 2016 value amounting to $6,000.

  • SELLAS Life Sciences Group's Capital Expenditures fell 85.93% to $104,000 in Q3 2013 from the same period last year, while for Sep 2013 it was $2.8 million, marking a year-over-year decrease of 6.26%. This contributed to the annual value of $6,000 for FY2016, which is 98.88% down from last year.
  • SELLAS Life Sciences Group's Capital Expenditures amounted to $6,000 in FY2016, which was down 98.88% from $534,000 recorded in FY2015.
  • SELLAS Life Sciences Group's 5-year Capital Expenditures high stood at $15.5 million for FY2013, and its period low was $6,000 during FY2016.
  • Its 3-year average for Capital Expenditures is $1.2 million, with a median of $534,000 in 2015.
  • Data for SELLAS Life Sciences Group's Capital Expenditures shows a maximum YoY tumbled of 98.88% (in 2016) over the last 5 years.
  • SELLAS Life Sciences Group's Capital Expenditures (Yearly) stood at $15.5 million in 2013, then crashed by 80.32% to $3.1 million in 2014, then plummeted by 82.53% to $534,000 in 2015, then crashed by 98.88% to $6,000 in 2016.